This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE:
Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute are granted U.S. Patent No. 8,716,017 entitled, Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells.
San Diego, CA (PRWEB) May 08, 2014
Xcelthera Inc, a major innovator in the stem cell research market and one of the first U.S. companies formed for clinical applications of human embryonic stem cell (human ES cell) therapeutic utility for unmet medical needs, and its joint research partner San Diego Regenerative Medicine Institute announced today that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. 8,716,017 entitled, Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells. This newly-issued patent is the first among a portfolio of intellectual property of Xcelthera Inc covering PluriXcel human stem cell technology platform for large-scale production of high quality clinical-grade pluripotent human ES cell lines and their functional human neuronal and heart muscle cell therapy products.
Neurodegenerative and heart diseases are major health problems and cost the worldwide healthcare system more than $500 billion annually. The limited capacity of these two cell systems -- neurons and cardiomyocytes -- for self-repair makes them suitable for stem cell-based neuronal and heart therapies. Nevertheless, to date, the existing markets lack a clinically-suitable human neuronal cell source or cardiomyocyte source with adequate regenerative potential, which has been the major setback in developing safe and effective cell-based therapies for neurodegenerative and heart diseases. Xcelthera proprietary PluriXcel technology allows efficient derivation of clinical-grade human ES cell lines and direct conversion of such pluripotent human ES cells by small molecule induction into a large commercial scale of high quality human neuronal or heart muscle cells, which constitutes clinically representative progress in both human neuronal and cardiac therapeutic products for treating neurodegenerative and heart diseases.
PluriXcel technology of Xcelthera Inc is milestone advancement in stem cell research, offering currently the only available human cell therapy products with the pharmacological capacity to regenerate human neurons and contractile heart muscles that allow restitution of function of the central nervous system (CNS) and heart in the clinic. Through technology license agreement with San Diego Regenerative Medicine Institute, Xcelthera Inc has become the first in the world to hold the proprietary breakthrough technology for large-scale production of high quality clinical-grade pluripotent human ES cell lines and their functional human neuronal and heart cell therapy products for commercial and therapeutic uses.
As neurodegenerative and heart diseases incur exorbitant costs on the healthcare system worldwide, there is a strong focus on providing newer and more efficient solutions for these therapeutic needs. Millions of people are pinning their hopes on stem cell research. PluriXcel technology platform of Xcelthera Inc is incomparable, providing life scientists and clinicians with novel and effective resources to address major health concerns. Such breakthrough stem cell technology has presented human ES cell therapy derivatives as a powerful pharmacologic agent of cellular entity for a wide range of incurable or hitherto untreatable neurodegenerative and heart diseases. Introduction of medical innovations and new business opportunities based on PluriXcel technology will shape the future of medicine by providing pluripotent human ES cell-based technology for human tissue and function restoration, and bringing new therapeutics into the market.
About Xcelthera Inc.
Xcelthera INC (http://www.xcelthera.com) is a new biopharmaceutical company moving towards clinical development stage of novel and most advanced stem cell therapy for a wide range of neurological and cardiovascular diseases with leading technology and ground-breaking medical innovation in cell-based regenerative medicine. The Company was recently incorporated in the state of California to commercialize the technologies and products developed, in part, with supports by government grants to the founder, by San Diego Regenerative Medicine Institute (SDRMI), an non-profit 501C3 tax-exempt status independent biomedical research institute that is interested in licensing its PATENT RIGHTS in a manner that will benefit the public by facilitating the distribution of useful products and the utilization of new processes, but is without capacity to commercially develop, manufacture, and distribute any such products or processes. Xcelthera is a major innovator in the stem cell research market and one of the first companies formed for clinical applications of human embryonic stem cell (human ES cell) therapeutic utility for unmet medical needs. The Company is the first to hold the proprietary breakthrough technology for large-scale production of high quality clinical-grade pluripotent human ES cell lines and their functional human neuronal and heart muscle cell therapy products for commercial and therapeutic uses. The Company owns or has exclusive rights in a portfolio of intellectual property or license rights related to its novel PluriXcel human stem cell technology platforms and Xcel prototypes of human stem cell therapy products. The inception of Xcelthera is driven by the urgent need for clinical translation of human ES cell research discoveries and innovations to address unmet medical challenges in major health problems. Xcelthera breakthrough developments in human ES cell research dramatically increase the overall turnover of investments in biomedical sciences to optimal treatment options for a wide range of human diseases. The overall strategy of the Company is to use cutting-edge human stem cell technology to develop clinical-grade functional human neural and cardiac cell therapy products from pluripotent human ES cells as cellular medicine or cellular drugs to provide the next generation of cell-based therapeutic solutions for unmet medical needs in world-wide major health problems. The Company is currently offering Series A Convertible Preferred Stock to accredited investors through equity crowdfunding to raise fund for its pre-IPO business operation and filing confidential IPO as an emerging growth company according to the JOBS Act to create a public market for its common stock and to facilitate its future access to the public equity market and growth of the Company.
- Vet-Stem Medistem Cellmedicine Rheumatoid Arthritis Stem Cell Video.mp4 - March 23rd, 2011 [March 23rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - March 26th, 2011 [March 26th, 2011]
- Macular Degeneration Improved With Stem Cells - March 31st, 2011 [March 31st, 2011]
- The Stem Cell Institute - April 2nd, 2011 [April 2nd, 2011]
- Cells That Heal Us From Cradle To Grave: A Quantum Leap in Medical Science - April 7th, 2011 [April 7th, 2011]
- Stem Cell Treatment Doing Wonders For Autistic Boy - April 9th, 2011 [April 9th, 2011]
- Explore Health Don Margolis part1 - April 15th, 2011 [April 15th, 2011]
- Explore Health Carlos Lima - One Step at a Time - May 19th, 2011 [May 19th, 2011]
- Stem Cell Patient Richard H. MS Treatment - May 20th, 2011 [May 20th, 2011]
- Visions Episode 92: Stem Cells Discovery - May 20th, 2011 [May 20th, 2011]
- Chemistry Tutorial 12.2c: Voltaic Cells - Practice - May 20th, 2011 [May 20th, 2011]
- Gene Doping: Super Athletes in 2008 Beijing Olympics - May 22nd, 2011 [May 22nd, 2011]
- Bacteria Cell - May 22nd, 2011 [May 22nd, 2011]
- Stem Cell Game 1 - Stem Cell Wrangler - May 24th, 2011 [May 24th, 2011]
- RSCI Don Margolis on Repair Stem Cells - May 30th, 2011 [May 30th, 2011]
- Mitosis - cell reproduction - June 1st, 2011 [June 1st, 2011]
- PROSTATE CANCER and stem cells.wmv - June 3rd, 2011 [June 3rd, 2011]
- Ah! So you can raise your power after all! - June 3rd, 2011 [June 3rd, 2011]
- BioEDEN European Stem Cell Bank - June 12th, 2011 [June 12th, 2011]
- Stem Cells Used to Grow Windpipes - June 15th, 2011 [June 15th, 2011]
- Stem Cell Game 3- Grow with the Flow - June 17th, 2011 [June 17th, 2011]
- Genetically modified kiwi - June 20th, 2011 [June 20th, 2011]
- Nurse Jackie Title Sequence - June 21st, 2011 [June 21st, 2011]
- Wrapsol Installation Video - Apple iPad - Original Front + Back - July 4th, 2011 [July 4th, 2011]
- Explore Health Don Margolis part2 - July 4th, 2011 [July 4th, 2011]
- Explore Health Carlos Lima and Christopher Reeve - July 10th, 2011 [July 10th, 2011]
- Oxidative stress: redox imbalance - July 14th, 2011 [July 14th, 2011]
- PROSTATE CANCER and stem cells - July 25th, 2011 [July 25th, 2011]
- Buy Priligy - July 28th, 2011 [July 28th, 2011]
- Stem Cell Therapy for Cerebral Palsy - Holly Catalano - August 2nd, 2011 [August 2nd, 2011]
- [Industry professional news channel itsTV] Weekly News Brief_0812 - August 20th, 2011 [August 20th, 2011]
- Sims 2 Mafia Story Part 7 - Farewell, Godfather/Stem Cell Medicine - August 30th, 2011 [August 30th, 2011]
- Doctors Use Stem Cells to Grow New Windpipes - August 31st, 2011 [August 31st, 2011]
- A New Way to Make Induced Pluripotent Stem Cells - September 5th, 2011 [September 5th, 2011]
- Stem Cell Research: Huntington's Disease - September 8th, 2011 [September 8th, 2011]
- Stem Cell Research: Huntington's Disease - September 8th, 2011 [September 8th, 2011]
- Regenerative Medicine and Applications of Stem Cell Research - September 9th, 2011 [September 9th, 2011]
- Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors - September 9th, 2011 [September 9th, 2011]
- Stem Cell Treatment for Autism: Community Outreach Miami, Florida - May 2011 - September 10th, 2011 [September 10th, 2011]
- Susan Lim: Transplant cells, not organs - September 11th, 2011 [September 11th, 2011]
- Chiropractic Sports Medicine - September 11th, 2011 [September 11th, 2011]
- Living With and Managing Sickle Cell Disease - September 14th, 2011 [September 14th, 2011]
- WHO Finding Adds to Debate Over Mobile Phones, Brain Cancer - September 14th, 2011 [September 14th, 2011]
- Tionne "T-Boz" Watkins of TLC on Celebrity Medical Nightmares - September 16th, 2011 [September 16th, 2011]
- Tionne "T-Boz" Watkins of TLC on Celebrity Medical Nightmares - September 16th, 2011 [September 16th, 2011]
- Jello Biafra @ Rebellion 2011 - The Cell and Holiday in Cambodia - September 16th, 2011 [September 16th, 2011]
- CIRM Bridges: Training the Next Generation of Stem Cell Scientists - September 17th, 2011 [September 17th, 2011]
- David Kekich - Regenerative Medicine (Part 1/6) - September 17th, 2011 [September 17th, 2011]
- Coast To Coast AM - 9.6.2011 - 1/4 - US Collapse - September 18th, 2011 [September 18th, 2011]
- What Is Personalized Medicine? - September 21st, 2011 [September 21st, 2011]
- Stem Cells and a Brief Mention of Bacon - September 21st, 2011 [September 21st, 2011]
- Adult Stem Cell Sucess Stories - Laura Dominguez - September 23rd, 2011 [September 23rd, 2011]
- Is Regenerative Medicine Hype or Hope? - September 24th, 2011 [September 24th, 2011]
- How to Buy Bitcoin - by 'The Bitcoin Show' on OnlyOneTV.com - September 25th, 2011 [September 25th, 2011]
- How to Buy Bitcoin - by 'The Bitcoin Show' on OnlyOneTV.com - September 25th, 2011 [September 25th, 2011]
- Samsung Galaxy S2 Unboxing - September 25th, 2011 [September 25th, 2011]
- Finding Forest Planets (Brainstorm Ep8) - September 26th, 2011 [September 26th, 2011]
- iPhone 3GS mobile signal problem - The Computer Room Nottingham - September 30th, 2011 [September 30th, 2011]
- Mobile Devices' Location Tracking Raises Privacy Concerns - October 2nd, 2011 [October 2nd, 2011]
- Mobile Devices' Location Tracking Raises Privacy Concerns - October 2nd, 2011 [October 2nd, 2011]
- 21st Century Stem Cell Scientists: The CIRM Creativity Awards - October 4th, 2011 [October 4th, 2011]
- Towing An Iceberg to Africa, wait what? (Brainstorm Ep18) - October 4th, 2011 [October 4th, 2011]
- Need a New Liver? Then Just Print Yourself One - October 4th, 2011 [October 4th, 2011]
- The potential of amniotic fluid stem cells - October 4th, 2011 [October 4th, 2011]
- INCREDIBLE Nucleus Medical Media 2011 Demo - October 4th, 2011 [October 4th, 2011]
- Stem Cell Treatments for Autism: Community Outreach Miami, Florida - Juliana Ubinas - October 4th, 2011 [October 4th, 2011]
- Bruce Lipton: being a cell of Humanity - October 4th, 2011 [October 4th, 2011]
- Sensitiv Imago medical device - October 4th, 2011 [October 4th, 2011]
- New Lymphoma Drug SGN-35 - The Nebraska Medical Center - October 4th, 2011 [October 4th, 2011]
- Rockefeller University Press Conference 2011 Nobel Prize in Physiology or Medicine to Ralph Steinman - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy and Stem Cell Treatments - Tim's Testimonial - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy and Stem Cell Treatments - Tim's Testimonial - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy - October 5th, 2011 [October 5th, 2011]
- Stem Cells-Iran-08-28-2011 - October 5th, 2011 [October 5th, 2011]
- After Brain Study, New Questions About Mobile Phones - October 5th, 2011 [October 5th, 2011]
- Judy Roberson: Patient advocates drive stem cell scientists - October 5th, 2011 [October 5th, 2011]
- Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury - October 5th, 2011 [October 5th, 2011]
- Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury - October 5th, 2011 [October 5th, 2011]
- Dangers of Continued Use of Cell Phones-Pulse Sep 03, Part 2 - October 5th, 2011 [October 5th, 2011]
- 2011 Nobel Prize in Medicine - October 5th, 2011 [October 5th, 2011]